Pharmaniaga to produce Sinovac Covid-19 vaccines

The vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga’s wholly-owned subsidiary, Pharmaniaga LifeSciences Sdn Bhd, in Puchong, Selangor, Pharma Niaga MD Zulkarnain Md Eusope told reporters after the signing of an agreement between pharmaniaga and Sinovac Life Sciences Co Ltd yesterday.

KUALA LUMPUR: Phamaniaga Bhd has the capacity to manufacture two million doses of Covid-19 vaccine developed by China’s Sinovac Life Sciences Co Ltd per month beginning March this year.

Group managing director Datuk Zulkarnain Md Eusope said the vaccine would be the first to be manufactured in Malaysia at the small volume injectable high-tech plant owned by Pharmaniaga’s wholly-owned subsidiary, pharmaniaga LifeSciences Sdn Bhd, in Puchong, Selangor.